¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"methyl cysteine hydrochloride"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • phenylhyrazine hydrochloride
    ¿°»ê¿°Æä´ÒÈ÷µå¶óÁø.
  • piperoxane hydrochloride
    ¿°»êÇÇÆä·Ï»ê.
  • pyridoxine hydrochloride
    ¿°»ê(ç¤ß«)ÇǸ® µ¶½Å.
  • trihexyphenidyl hydrochloride
    ¿°»ê(ç¤ß«)Æ®¸®Çí½ÃÆä´Ïµô.
  • tyramine hydrochloride
    ¿°»ê Ƽ¶ó¹Î
  • chloromethyl methyl ether
    Ŭ·Î·Î¸ÞÅÚ¿¡Å׸£
  • labile methyl group
    ºÒ¾ÈÁ¤¸ÞÆ¿±â.
  • methyl alcohol
    ¸ÞÆ¿¾ËÄÝ.
  • methyl alcohol
    ¸ÞÆ¿¾ËÄÚ¿Ã
  • methyl alcohol intoxication
    ¸ÞÆ¿¾ËÄÝÁßµ¶.
  • methyl dopa
    ¸ÞÆ¿µµÆÄ.
  • methyl dopa therapy
    ¸ÞÆ¿µµÆÄÄ¡·á(¡­ö½èþ).
  • methyl group
    ¸ÞÆ¿±â.
  • methyl nicotinamide
    ¸ÞÆ¿´ÏÄÚÆ¾¾Æ¹Ìµå.
  • methyl pentosan
    ¸ÞÆ¿ÆæÅä»ê.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MPMP 10[(1-methyl-3-piperidinyl)-methyl]-1OH-phenothiazine
CAAX [box] protein segment in which C is cysteine, A is usually but not always an aliphatic amino acid, and X i...
CPI California Personality Inventory; Cancer Potential Index; congenital palatopharyngeal incompetence; ...
CPLM cysteine-peptone-liver infusion medium
CRIP cysteine-rich intestinal protein
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
GdnHCl guandine hydrochloride
GuHCl Guanidine hydrochloride
L-NAME N(G)-Nitro-L-arginine methylester hydrochloride
PPA Phenylpropanolamine hydrochloride
P-4 Propiverine hydrochloride
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cocaine hydrochloride
    ¿°»ê ÄÚÄ«ÀÎ
  • diltiazem hydrochloride
    ¿°»ê ´ÙÀÏÆ¼¾ÆÁª
    °ü»ó Ç÷°ü È®ÀåÁ¦, Çù½ÉÁõÀÇ ´ëÁõ¿ä¹ý¿¡ »ç¿ëÇÑ´Ù,
  • dimethisoquin hydrochloride
    ¿°»ê ´ÙÀÌ¸ÞÆ¼¼ÒÄý
    ¹é»ö ¹«ÃëÀÇ ºÐ¸». ¹°, ¾ËÄÝ, Ŭ·Î·ÎÆ÷¸§¿¡³ìÀ¸¸ç ±¹¼Ò¸¶ÃëÁ¦·Î »ç¿ëµÈ´Ù.
  • diphenhydramine hydrochloride
    ¿°»ê ´ÙÀÌÆæÇÏÀ̵å¶ó¹Î
    ¹é»ö ¹«ÃëÀÇ °áÁ¤¼º ºÐ¸». ¸¶Ã뼺 Áö»çÁ¦
  • ephedrine hydrochloride
    ¿°»ê ¿¡Æäµå¸°
  • ethylmorphine hydrochloride
    ¿¡Æ¿ ¸ð¸£ÇÉ ¿°»ê ¿°
  • hydralazine : ¹«»ö °¡½º»óÀÇ diamine. H2N?NH2. ¶ÇÇÑ ±× À¯µµÃ¼ÀÇ Àϱºµµ Æ÷ÇÔÇÑ´Ù.

    hydralazine hydrochloride

    ¿°»ê ÇÏÀ̵å¶ö¶óÁø
    ¹é»ö ¹«ÃëÀÇ ºÐ¸». ¹°¿¡ ³ì±â ¾î·Á¿ì¸ç, Ç÷¾Ð °­ÇÏÁ¦·Î¼­ °íÇ÷¾Ð Ä¡·á¿¡ »ç¿ëÇÑ´Ù.
  • Labetalol hydrochloride

    labia (À½¼ø, ÀÔ¼ú, ±¸¼ø

    ÀÔ¼úÀÇ, ÀÔ¼ú¿¡ °üÇÑ, ÀÔ¼úÀ» ÇâÇÑ.
  • lidocaine hydrochloride
    ¿°»ê ¸®µµÄ«ÀÎ
    ±¹¼Ò ¸¶ÃëÁ¦ÀÇ ÀÏÁ¾.
  • lucanthone hydrochloride
    ¿°»ê ·çÄ­Åæ
    ºôÇϸ£Âê ¿­¿¡ ´ëÇÑ Ä¡·áÁ¦.
  • meclizine hydrochloride
    ¿°»ê ¸ÞŬ¸®Áø
    1-[
  • methixene hydrochloride
    ¿°»ê ¸Þƽ½Å
    ¹é»ö °áÁ¤¼º ºÐ¸». Ç×Äݸ°Á¦·Î¼­ ÆòȰ±Ù¿¡ ´ëÇØ¼­ Á÷Á¢ÀûÀÎ Áø°æÀÛ¿ëÀÌ ÀÖ´Ù. Àå°üÀÇ ±â´ÉÀå¾Ö¸¦ µ¿¹ÝÇÑ À§ÀåÀÇ ¿îµ¿ Ç×Áø°ú °æ·ÃÀÇ Ä¡·á¿¡ »ç¿ëµÇ¸ç °æ±¸·Î Åõ¿©ÇÑ´Ù.
  • methoxamine hydrochloride
    ¿°»ê ¸Þ·Ï»ç¹Î
    ¹«»ö ¶Ç´Â ¹é»ö ÆÇ»ó °áÁ¤ ¶Ç´Â ¹é»ö °áÁ¤¼º ºÐ¸». ¾Æµå·¹³¯¸°¼º ÀÚ±ØÁ¦À̸ç Ç÷°ü ¼öÃàÁ¦·Î¼­ ¸¶Ãë ±â°£¿¡ Ç÷¾ÐÀ» À¯ÁöÇϱâ À§Çؼ­, ¶Ç´Â ¹ßÀÛ¼º »ó½Ç¼º ºó¹ÚÀÇ Ä¡·á¿¡ »ç¿ëµÇ¸ç ±ÙÀ° ÁÖ»ç ¶Ç´Â Á¤¸Æ ÁÖ»çÇÑ´Ù.
  • nafoxidine hydrochloride
    ¿°»ê ³ªÆø½Ãµò
    Ç׿¡½ºÆ®·Î°ÕÁ¦·Î¼­ À¯¹æ¾Ï Ä¡·á¿¡ »ç¿ëµÈ´Ù.
  • naphazoline hydrochloride
    ¿°»ê ³ªÆÄÁ¹¸°
    ¹é»ö °áÁ¤¼º ºÐ¸». ¾Æµå·¹³¯¸°¼º ÀÛ¿ë ¹°Áú·Î¼­ Ç÷°ü¼öÃàÁ¦·Î »ç¿ëµÇ¸ç ºñ Á¡¸· ¶Ç´Â ¾È Á¡¸·¿¡ ±¹¼ÒÀûÀ¸·Î Àû¿ëÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
cysteine string protein <protein> (CSPs) Peripheral membrane proteins that contain more than 10 palmitoylated cysteines and a DNA J homology domain. Nature 375:647
(18 Nov 1997)
cysteine sulfinate desulfinase <enzyme> Catalyses removal of elemental sulfur and selenium atoms from cysteine, cystine, selenocysteine and selenocystine to produce l-alanine.
Registry number: EC 4.4.1.-
(26 Jun 1999)
cysteine sulfinic acid -O2S-CH2CH (NH3)+COO-;a natural oxidation product of cysteine; an intermediate in the formation of taurine (via cysteic acid).
(05 Mar 2000)
cysteine synthase <enzyme> An enzyme that catalyses the biosynthesis of cysteine in microorganisms and plants from o-acetyl-l-serine and hydrogen sulfide.
Chemical name: O(3)-Acetyl-L-serine acetate-lyase (adding hydrogen sulfide)
Registry number: EC 4.2.99.8
(12 Dec 1998)
Onchocerca volvulus L3 cysteine protease <enzyme> Required for molting of o. Volvulus third stage larvae; genbank u71150
Registry number: EC 3.4.22.-
Synonym: cysteine protease l3, o volvulus, lovcp
(26 Jun 1999)
L-cysteine-cystine C-S lyase <enzyme> C-des - cysteine desulfhydrase; a pyridoxal phosphate- containing enzyme from synechocystis involved information of fe-s cluster of ferredoxin; catalyses the breakdown of l-cysteine to yield sulfide, pyruvate and ammonia; increased activity with cystine, yielding cysteine persulfide as the primary product; mw about 43 kD
Registry number: EC 4.4.1.-
Synonym: c-des lyase
(26 Jun 1999)
active methyl A methyl group attached to a quaternary ammonium ion or a tertiary sulfonium ion that can take part in transmethylation reactions; e.g., methyl groups in choline and in S-adenosyl-l-methionine, which are thus methyl donors.
(05 Mar 2000)
aklanonic acid methyl ester cyclase <enzyme> Catalyses the formation of aklaviketone from aklanonic acid methyl ester; involved in daunomycin biosynthesis; see also daunorubicin-doxorubicin polyketide synthase
Registry number: EC 5.-
Synonym: aame cyclase, daud protein, daud gene product, dnrd protein, dnrd gene product
(26 Jun 1999)
alpha-(4-O-methyl)-D-glucuronidase <enzyme> Removes 4-o-methyl-glucopyranosyl uronic acid residues from the 2-position of fungal cell wall xylans
Registry number: EC 3.2.1.-
Synonym: 4-o-methyl-glucuronidase
(26 Jun 1999)
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid <chemical> Alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid. An ibotenic acid homolog and glutamate agonist. The compound is the defining agonist for the ampa subtype of glutamate receptors (receptors, ampa). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
Pharmacological action: excitatory amino acid agonists.
Chemical name: 4-Isoxazolepropanoic acid, alpha-amino-2,3-dihydro-5-methyl-3-oxo-
(12 Dec 1998)
alpha methyl dopa <drug> An antihypertensive drug, preferred in pregnant patients.
(18 Nov 1997)
angular methyl A methyl group attached to carbon 10 (between rings A and B) or to carbon 13 (between rings C and D) of the steroid nucleus.
(05 Mar 2000)
bevonium methyl sulfate 2-(hydroxymethyl)-1,1-dimethylpiperidinium methyl sulfate benzylate;an anticholinergic agent.
Synonym: pyribenzyl methyl sulfate.
(05 Mar 2000)
Mann's methyl blue-eosin stain <technique> A stain useful for anterior pituitary and viral inclusion bodies; a mixture of the two dyes stains alpha cell granules red, beta cell granules dark blue, chromophobes gray to pink, colloid red, erythrocytes orange-red, and collagen fibres blue; this method is also useful for enterochromaffin, goblet, Paneth, and pancreatic islet cells; Negri bodies appear red while their nuclei and central granules are blue.
(05 Mar 2000)
receptors, n-methyl-d-aspartate A class of ionotropic glutamate receptors characterised by affinity for n-methyl-d-aspartate. Nmda receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á